oxycodone has been researched along with Aging in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brownstein, AJ; Buonora, M; Correa da Rosa, J; Ho, A; Kreek, MJ; Niikura, K; Ott, J; Zhang, Y | 1 |
Butelman, ER; Ho, A; Kreek, MJ; Picetti, R; Schlussman, SD; Zhang, Y | 1 |
Amory, JK; Cherrier, MM; Ersek, M; Risler, L; Shen, DD | 1 |
Ihmsen, H; Neuvonen, PJ; Olkkola, KT; Saari, TI; Schwilden, H | 1 |
Anttila, E; Olkkola, KT; Pokela, ML; Seppälä, T | 1 |
Elsner, F; Gaertner, J; Gerbershagen, H; Giesecke, T; Ostgathe, C; Petzke, F; Radbruch, L; Sabatowski, R | 1 |
1 review(s) available for oxycodone and Aging
Article | Year |
---|---|
Oxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic study.
Topics: Adult; Aged; Aged, 80 and over; Aging; Analgesics, Opioid; Body Mass Index; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Oxycodone; Young Adult | 2012 |
2 trial(s) available for oxycodone and Aging
Article | Year |
---|---|
Comparative cognitive and subjective side effects of immediate-release oxycodone in healthy middle-aged and older adults.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aging; Attention; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Geriatric Assessment; Humans; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Oxycodone; Pain; Pain Measurement; Risk Factors; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome | 2009 |
Marked variation in oxycodone pharmacokinetics in infants.
Topics: Aging; Analgesics, Opioid; Area Under Curve; Female; Half-Life; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Oxycodone | 2005 |
3 other study(ies) available for oxycodone and Aging
Article | Year |
---|---|
Self administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice.
Topics: Aging; Animals; Cadherins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP Response Element Modulator; Gene Expression; Gene Expression Regulation, Developmental; Hippocampus; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Narcotics; Opioid-Related Disorders; Oxycodone; Proto-Oncogene Proteins c-pim-1; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; RNA, Messenger; Self Administration | 2015 |
Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.
Topics: Aging; Analysis of Variance; Animals; Behavior, Addictive; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Mice; Mice, Inbred C57BL; Models, Statistical; Oxycodone; Self Administration | 2009 |
Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients.
Topics: Adult; Aged; Aging; Analgesics, Opioid; Arousal; Attention; Automobile Driving; Cognition; Delayed-Action Preparations; Endpoint Determination; Female; Germany; Humans; Male; Middle Aged; Oxycodone; Psychomotor Performance | 2006 |